Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep 1;19(17):5176-81.
doi: 10.1016/j.bmcl.2009.07.025. Epub 2009 Jul 9.

Semi-rigid tripeptide agonists of melanocortin receptors

Affiliations

Semi-rigid tripeptide agonists of melanocortin receptors

Andrew R Ruwe et al. Bioorg Med Chem Lett. .

Abstract

A series of 30 RCO-HfR-NH(2) derivatives show preference for the mouse MC1R vs MC3-5Rs. trans-4-HOC(6)H(4)CH=CHCO-HfR-NH(2) (13) [EC(50) (nM): MC1R 83, MC3R 20500, MC4R 18130 and MC5R 935; ratio 1:246:217:11] is 11 times more potent than the lead compound LK-394 Ph(CH(2))(3)CO-HfR-NH(2) (2) and only 11 times less potent than the native tridecapeptide alpha-MSH at mMC1R. Differences in conformations of 2 and 13 are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Conformations within 5 kcal/mol: a. Ph(CH2)3CO-His-D-Phe-Arg-NH2 (2), b. trans-4-HOC6H4CH=CHCO-His-D-Phe-Arg-NH2 (13).

Similar articles

Cited by

References

    1. The Melanocortin Receptors; Cone RD, editor. Humana. Totowa: 2000. Abdel-Malek Z. Cell Molec Life Sci. 2001;58:1420.Understanding G Protein-coupled Receptors and their Role in the CNS (The Molecular and Cellular Neurobiology Series); Pangalos M, Davies CH, editors. Oxford University Press; 2002. Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C. Pigment Cell Res. 2005;18:393.Wikberg JES, Mutulis F. Nature Rev Drug Disc. 2008;7:307.

    1. Todorovic A, Haskell-Luevano C. Peptides. 2005;26:2026.Hadley ME, Hruby VJ, Jiang J, Sharma SD, Fink JL, Haskell-Luevano C, Bentley DL, Al-Obeidi F, Sawyer TK. Pigment Cell Res. 2006;9:213.Insights into Receptor Function and New Drug Development Targets (Research and Perspectives in Endocrine Interactions); Conn M, Kordon C, Christen Y, editors. Springer; 2006. Ligand Design for G Protein-coupled Receptors (Methods and Principles in Medicinal Chemistry); Rognan D, Mannhold R, Kubinyi H, Folkers G, editors. Wiley-VCH; 2006. Current Top Med Chem. 2007;7No 11 – a special issue on Melanocortin Receptor Ligands and Their Potential Therapeutic Uses; Nozawa D, Chaki S, Nakazato A. Expert Opinion Ther Patents. 2008;18:403.

    1. Koikov LN, Knittel JJ, Solinsky MG, Cross-Doersen D, Ebetino FH. Bioorg Med Chem Lett. 2003;13:2647. - PubMed
    2. 2004;14:3997. ibid.
    1. Abdel-Malek ZA, Kadekaro AL, Kavanagh RJ, Todorovic A, Koikov LN, McNulty JC, Pilgrim JJ, Jackson PJ, Millhauser GL, Schwenberger S, Babcock J, Haskell-Luevano C, Knittel JJ. The FASEB Journal. 2006;20:1561. - PubMed
    2. Abdel-Malek ZA, Kavanagh RJ, Koikov LN, Todorovic A, Haskell-Luevano C, McNulty JC, Jackson P, Millhauser G, Knittel JJ. Pigment Cell Res. 2004;17:449.
    3. Hearing VJ, Rouzaud F. Peptides. 2005;26:1858. - PubMed
    4. Abdel-Malek ZA, Knittel JJ, Kadekaro AL, Starner R, Swope VB. Photochem Photobiol. 2008;84:501. - PubMed
    1. Haskell-Luevano C, Holder JR, Monck EK, Bauzo RM. J Med Chem. 2001;44:2247. - PubMed

Publication types

LinkOut - more resources